Bioinformatics: Technologies and Global Markets

Dec 2023| BIO051G| BCC Publishing

Report Highlights

The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.

Report Includes

  • 123 data tables and 90 additional tables
  • An up-to-date overview and industry analysis of the global bioinformatics market
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the market size and revenue forecast for the global bioinformatics market, and corresponding market share analysis based on solution, hardware type, application, sequencing services and platforms, end use, and region
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
  • Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
  • Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
  • Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
  • Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
  • A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
  • Patent analysis covering significant allotments of recent patent grants across each major category
  • Profile descriptions of the leading market players

Report Scope

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

By solution, hardware application, sequencing services and platform, end user, and geography, the market has been segmented into the North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and Australia will be covered in each country’s respective regional segment. In the market valuations, 2022 serves as the base year, while estimated values are provided for 2023 and forecast values for 2028.

Frequently Asked Questions (FAQs)

The market is projected to grow from $16.5 billion in 2022 to $35.5 billion in 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period.
The key factors driving the growth of the Bioinformatics Technologies and Global Market.
  • Rise in Adoption of ChatGPT.
  • Increase in Integrated Artificial Intelligence Software
  • Data Science Inclusion in Bioinformatics
  • Rise in funding for Genomic Study in different countries.
The Bioinformatics Technologies and Global Market is segmented based on:
  • Application.
  • End user.
  • Solution.
  • Hardware Type.
  • Sequencing Analysis of Platform and Services.
  • Country wise segmentation.
By Application, genomics segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $16.5 billion
Market size forecast $35.5 billion
Growth rate CAGR of 13.6% from 2023 to 2028
Units considered $ Millions
Segments covered By Solution, Hardware Type, Application, Sequencing Services and Platforms, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered The U.S., Canada, Mexico, Brazil, Germany, France, Italy, Spain, United Kingdom, China, Japan, India, Australia and New Zealand (ANZ), and GCC countries
Key Market Drivers
  • New Discoveries in Biological Sciences
  • Increasing Use of Bioinformatics Analytical Software
  • New Antibody Technologies and Antibody Types
  • Antibody-Based Drug Discovery and Development
  • Developed and Increasing Research Areas
  • Increased Government Funding in Emerging Markets
  • Need for Further Human Genomic and Proteomic Research
  • New Application-Focused Technology Platforms
Companies studied
  • 3RD MILLENNIUM INC.
  • AITIA
  • AGILENT TECHNOLOGIES INC.
  • ARAGEN LIFE SCIENCES LTD.
  • BIOMATTERS LTD. GENEIOUS
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES BIOVIA
  • DNASTAR INC.
  • GENEDATA AG
  • GENEVA BIOINFORMATICS (GENEBIO) SA
  • ILLUMINA INC.
  • INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
  • MACVECTOR INC.
  • MOLECULAR CONNECTIONS PVT. LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKINELMER INFORMATICS INC.
  • PERSONALIS INC.
  • QLUCORE AB
  • REAL TIME GENOMICS
  • SMARTGENE SERVICES SARL
  • SYNGENE INTERNATIONAL LTD.
  • THERMO FISHER SCIENTIFIC INC.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Bioinformatics: Technologies and Global Markets481Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview27Free
Chapter- 4: Market Dynamics11Free
Chapter- 5: Market Breakdown by Application69Free
Chapter- 6: Market for Sequencing Services and Platforms12Free
Chapter- 7: Market Breakdown by Solution53Free
Chapter- 8: Market Breakdown by End Use21Free
Chapter- 9: Market Breakdown by Region150Free
Chapter- 10: ESG Development14Free
Chapter- 11: Bioinformatics Applications in Pharmaceutical R&D34Free
Chapter- 12: Emerging Technologies and Developments8Free
Chapter- 13: Qualitative Information on New Software4Free
Chapter- 14: M&A and Venture Funding Outlook16Free
Chapter- 15: Competitive Intelligence5Free
Chapter- 16: Company Profiles43Free
Chapter- 17: Appendix: Acronyms1Free
Published - Jun-2021| Analyst - BCC Publishing| Code - BIO051F

Report Highlights

The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.

Report Includes

  • 51 data tables and 84 additional tables
  • An overview of the global markets and technologies for bioinformatics
  • Analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Evaluation of market size and forecast, and market share analysis of bioinformatics based on categories, applications, sequence services and platforms, region, and end-users
  • Highlights of technological advancements and innovations in bioinformatics solutions for drug discovery and insights into investments and funding for the development of bioinformatics solutions
  • Assessment of challenges and opportunities in the bioinformatics market and description of high-throughput technologies such as next-generation sequencing (NGS), big data analysis and cloud-based solutions
  • Coverage of new discoveries in biological sciences; details of antibody-based drug discovery and development; prevalence of chronic diseases and impact analysis of COVID-19 on bioinformatics company
  • Identification of innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Illumina Inc., Genedata AG, Qlucore AB, GNS Healthcare Inc., Smartgene Services SARL and Real Time Genomics Inc.
Published - Dec-2019| Analyst - Vijay Laxmi| Code - BIO051E

Report Highlights

The global bioinformatics market should grow from $7.5 billion in 2018 to $20.0 billion by 2023, with a compound annual growth rate (CAGR) of 21.7% during the period of 2018-2023.

Report Includes

  • 31 data tables and 80 additional tables
  • Comprehensive details of the global bioinformatics market and relevant technologies
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
  • Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
  • Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
  • Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB and Syngene International
Published - Nov-2018| Analyst - Vijay Laxmi| Code - BIO051D

Report Highlights

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

Report Includes 

  • 28 data tables and 72 additional tables
  • An overview of the global market for bioinformatic technologies and their applications
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of the goal of bioinformatics and their role in systems biology
  • Insight into the application of bioinformatics on drug development, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • Detailed profiles of major companies in the market, including 3rd Millennium, Inc., Biomatters Ltd., Compugen Ltd., DNASTAR, Inc., and Illumina, Inc.
Published - Jan-2016| Analyst - Dr. Cheryl Lee Barton| Code - BIO051C

Report Highlights

The global bioinformatic market was $3.6 billion and $4.1 billion in 2013 and 2014, respectively. This market is expected to reach $8.0 billion in 2019 from $4.7 billion in 2015 at a compound annual growth rate of 14.2% for the period 2014-2019.

Report Includes

  • An overview of the global market for bioinformatics based on geography, category and application.
  • Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2019.
  • Technological descriptions and patenting trends in bioinformatics.
  • Analysis of the market's dynamics, including opportunities, drivers, and restraints.
  • Examination of the economic environment effecting the deployment of bioinformatics.
  • Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
  • Comprehensive company profiles of major players in the industry.
Published - Apr-2013| Analyst - Dr. Cheryl Lee Barton| Code - BIO051B

Report Highlights

The global bioinformatics market was valued at nearly $2.8 billion in 2011, nearly $3.2 billion in 2012, and is forecast to grow to nearly $7.5 billion by 2017 after increasing at a compound annual growth rate (CAGR) of 18.7%.

Report Includes

  • An overview of the global market for bioinformatics.
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Technological descriptions and patenting trends in bioinformatics.
  • Examination of the economic environment affecting the deployment of bioinformatics.
  • Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
Published - Aug-2005| Analyst - Evalueserve | Code - BIO051A

Report Highlights

  • The worldwide value of bioinformatics is expected to increase from $1.02 billion in 2002 to $3.0 billion in 2010, at an average annual growth rate (AAGR) of 15.8%.
  • The fastest growing market is expected to be analysis software and services. It is estimated to grow from $444.7 million in 2005 to $1.2 billion in 2010.
  • The application of bioinformatics in drug discovery and development is expected to reduce the annual cost of developing a new drug by 33%, and the time for drug discovery by 30%.
  • The pharmaceutical companies are expected to increase their R&D expenditures in the future and a major portion of this spending is expected to go into bioinformatics.

Bioinformatics: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS